Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: RRICH4 who wrote (14689)	6/25/2002 1:39:44 PM
From: Paul Senior	Read Replies (2) \| Respond to of 78601

RRICH4, I have a small position. There are two other areas that Inamed is involved with that I find interesting: 1. "Breast implants". 2. "Facial rejuvenation". There may be some investor interest eventually moving to Inamed's products. Right now it seems to be "BOTOX", Allergan's (AGN) product, that's getting all the attention. Not sure I'd call it a value stock though. OTOH, if AGN, BMY, SGP, etc. get mentioned here, then IMDC is worth a mention and consideration. finance.yahoo.com

To: RRICH4 who wrote (14689)	1/13/2006 1:06:38 AM
From: Paul Senior	Read Replies (1) \| Respond to of 78601

OT: Cosmetic surgery stuff. Have sold off most of my long term IMDC @ $86-87 (purchases @~$14 (1/01), ~$24 (5/02), $48 (9/04) $51 (12/04),and $59-60 (4/05)). Will participate in buyout offer from IGN for remaining shares and short-term held shares. Have started a small buy of competitor MRX. This week started an exploratory position in ELOS. In an ancillary way, regarding "parts suppliers", I continue to hold a few shares of SYK, SMA. finance.yahoo.com None of these stocks now is a value stock imo. Just posting 'cause I'm on the computer looking at these and have nothing better to do late tonight. -g-